The analyses evaluated three GLP-1 receptor agonists used for weight management and found that each one produced clinically important weight loss when compared with placebo
It will take a few weeks to start noticing big differences in your appetite but there will be some changes and you should be implementing a calorie controlled diet immediately
Patients are encouraged to report any persistent or concerning symptoms to their healthcare provider, even if not listed here
If you have a history of substance misuse, tell your clinician early, because that history can change which options are safest
You might experience fatigue, dizziness, gallbladder issues, and even loss of muscle mass
In animal models, retatrutide reduced food intake , body weight , and glycemic markers more than GLP-1 monotherapy and dual GLP-1/GIP agonists